The Early Access Committee on which Malecare sits has been successful in adding an additional site in Long Island, New York to the Early Access Trial of Radium-233 Chloride (Alpharadin) for men with advanced prostate cancer who are castrate resistant and have at least two (2) bone metastases.
If you are interested in this trial contact:
North Shore Long Island Medical Ctr
New Hyde Park, NY 11040
Contact: Kerry Ann Brown kbrown15@nshs.edu or (718) 470-4642
To learn more about this early access trial go to:
http://advancedprostatecancer.net/?p=3521
To learn more about Radium-233 Chloride (Alpharadin) go to:
http://advancedprostatecancer.net/?p=3289
http://advancedprostatecancer.net/?p=3545
Joel T. Nowak, M.A., M.S.W.
Source: http://advancedprostatecancer.net/?p=3549
wikipedia blackout kyla pratt justified season 3 custer scott walker restaurant week type 2 diabetes
কোন মন্তব্য নেই:
একটি মন্তব্য পোস্ট করুন